NCT02268604View on ClinicalTrials.gov

Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

October 31, 2010

Conditions
Healthy
Interventions
DRUG

BIIB 722 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY